Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Breath Research"
DOI: 10.1088/1752-7163/ac7a57
Abstract: Inhaled corticosteroids (ICS) are the mainstay of therapy in asthma, but benefits vary due to disease heterogeneity. Steroid insensitivity is a particular problem in severe asthma, where patients may require systemic corticosteroids and/or biologics. Biomarkers…
read more here.
Keywords:
breath biomarkers;
short medium;
exhaled breath;
severe asthma ... See more keywords